Combinations of Opioid/TLR4 Antagonists and Acetyl-Para-Aminophenol (APAP) for Use in the Treatment of Pain
AssigneeAllodynic Therapeutics, LLC
InventorAnnette Channa Toledano
Life of this patent
Estimating the term…
Abstract
Disclosed are compositions for the treatment of pain comprising a first compound and a second compound, the first compound is an opioid antagonist that treats pain by blocking Toll-like receptor 4 (TLR4) and the second compound is acetyl-para-aminophenol (APAP) that enhances the pain treatment effect of the first compound. Examples of opioid antagonist include naltrexone and naloxone, synergistic pharmaceutical compositions thereof, and their use in the treatment, prevention, and reversal of neuropathic and nociceptive pain.
Claims16
A composition for treatment of pain in a mammal comprising a synergistic ratio of an opioid/TLR4 antagonist, or pharmaceutically acceptable salts or solvates thereof and a acetyl-para-aminophenol, or pharmaceutically acceptable salts or solvates thereof.
Dependencies are inferred from the claim text.